Morgan Stanley
PGEN icon

Morgan Stanley’s Precigen PGEN Stock Holding History

Morgan Stanley’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.34M Sell
2,414,322
-779,201
-24% -$3.2M ﹤0.01% 3621
2025
Q4 		$13.3M Buy
3,193,523
+1,211,879
+61% +$4.69M ﹤0.01% 3334
2025
Q3 		$6.52M Sell
1,981,644
-59,330
-3% -$168K ﹤0.01% 3927
2025
Q2 		$2.9M Buy
2,040,974
+1,007,864
+98% +$1.43M ﹤0.01% 4469
2025
Q1 		$1.54M Sell
1,033,110
-86,501
-8% -$136K ﹤0.01% 4766
2024
Q4 		$1.25M Sell
1,119,611
-95,739
-8% -$81.7K ﹤0.01% 4973
2024
Q3 		$1.15M Buy
1,215,350
+208,046
+21% +$262K ﹤0.01% 4972
2024
Q2 		$1.59M Sell
1,007,304
-56,024
-5% -$81.4K ﹤0.01% 4696
2024
Q1 		$1.54M Sell
1,063,328
-1,465,290
-58% -$2.1M ﹤0.01% 4719
2023
Q4 		$3.39M Buy
2,528,618
+1,556,169
+160% +$1.83M ﹤0.01% 4632
2023
Q3 		$1.38M Buy
972,449
+32,089
+3% +$45.5K ﹤0.01% 4609
2023
Q2 		$1.08M Buy
940,360
+28,111
+3% +$33.2K ﹤0.01% 4782
2023
Q1 		$967K Buy
912,249
+80,868
+10% +$117K ﹤0.01% 4882
2022
Q4 		$1.26M Sell
831,381
-43,671
-5% -$75.1K ﹤0.01% 4729
2022
Q3 		$1.86M Sell
875,052
-27,106
-3% -$57.2K ﹤0.01% 4488
2022
Q2 		$1.21M Sell
902,158
-240,525
-21% -$357K ﹤0.01% 4903
2022
Q1 		$2.41M Buy
1,142,683
+176,318
+18% +$429K ﹤0.01% 4374
2021
Q4 		$3.59M Buy
966,365
+41,397
+4% +$178K ﹤0.01% 4074
2021
Q3 		$4.62M Sell
924,968
-297,887
-24% -$1.71M ﹤0.01% 3809
2021
Q2 		$7.97M Buy
1,222,855
+338,055
+38% +$2.36M ﹤0.01% 3259
2021
Q1 		$6.1M Buy
884,800
+160,121
+22% +$1.35M ﹤0.01% 3207
2020
Q4 		$7.39M Sell
724,679
-361,915
-33% -$2.35M ﹤0.01% 2840
2020
Q3 		$3.8M Buy
1,086,594
+403,960
+59% +$1.92M ﹤0.01% 2981
2020
Q2 		$3.41M Buy
682,634
+22,070
+3% +$75.1K ﹤0.01% 3062
2020
Q1 		$2.25M Sell
660,564
-81,081
-11% -$350K ﹤0.01% 3264
2019
Q4 		$4.07M Sell
741,645
-113,986
-13% -$642K ﹤0.01% 3424
2019
Q3 		$4.89M Buy
855,631
+244,153
+40% +$1.66M ﹤0.01% 2900
2019
Q2 		$4.68M Sell
611,478
-2,314,535
-79% -$12.5M ﹤0.01% 2972
2019
Q1 		$15.4M Sell
2,926,013
-906,630
-24% -$6.29M ﹤0.01% 1646
2018
Q4 		$25.1M Buy
3,832,643
+675,335
+21% +$7.57M 0.01% 1261
2018
Q3 		$54.4M Buy
3,157,308
+38,864
+1% +$578K 0.01% 922
2018
Q2 		$43.5M Buy
3,118,444
+196,999
+7% +$3.33M 0.01% 995
2018
Q1 		$44.8M Buy
2,921,445
+948,487
+48% +$13.6M 0.01% 994
2017
Q4 		$22.7M Sell
1,972,958
-151,617
-7% -$2.26M 0.01% 1558
2017
Q3 		$40.4M Buy
2,124,575
+7,704
+0.4% +$159K 0.01% 1034
2017
Q2 		$51M Sell
2,116,871
-34,932
-2% -$766K 0.02% 893
2017
Q1 		$42.6M Sell
2,151,803
-96,293
-4% -$2.15M 0.01% 1004
2016
Q4 		$54.1M Sell
2,248,096
-234,467
-9% -$6.53M 0.02% 827
2016
Q3 		$68.9M Sell
2,482,563
-221,199
-8% -$5.85M 0.02% 685
2016
Q2 		$65.9M Sell
2,703,762
-314,790
-10% -$8.93M 0.02% 665
2016
Q1 		$101M Sell
3,018,552
-172,144
-5% -$5.42M 0.04% 465
2015
Q4 		$95.3M Buy
3,190,696
+357,750
+13% +$12.1M 0.03% 512
2015
Q3 		$89.3M Buy
2,832,946
+1,927,132
+213% +$94M 0.03% 517
2015
Q2 		$43.8M Sell
905,814
-47,947
-5% -$2.02M 0.02% 948
2015
Q1 		$41.4M Buy
953,761
+117,808
+14% +$4.23M 0.02% 959
2014
Q4 		$22M Buy
835,953
+196,918
+31% +$4.32M 0.01% 1415
2014
Q3 		$11.3M Sell
639,035
-21,512
-3% -$439K ﹤0.01% 1914
2014
Q2 		$15.9M Buy
660,547
+74,154
+13% +$1.5M 0.01% 1620
2014
Q1 		$14.7M Buy
586,393
+141,484
+32% +$3.92M 0.01% 1635
2013
Q4 		$10.1M Sell
444,909
-59,628
-12% -$1.2M ﹤0.01% 1946
2013
Q3 		$11.4M Buy
+504,537
New +$11.6M 0.01% 1671

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Morgan Stanley's PGEN Position: Q1 2026 in Review

Morgan Stanley reduced its Precigen (PGEN) stake by 24% in Q1 2026, selling an estimated $3.2M and leaving 2,414,322 shares worth $9.34M. The position accounts for ﹤0.01% of the portfolio, ranked #3621.

Morgan Stanley first reported a position in PGEN in Q3 2013 and has held it in 51 quarters since. The position peaked at $101M in Q1 2016. 205 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

  • Morgan Stanley held 2,414,322 shares of Precigen worth $9.34M as of Q1 2026.
  • Morgan Stanley sold 779,201 Precigen shares in Q1 2026, an estimated $3.2M.
  • Precigen made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #3621 holding.
  • Morgan Stanley first reported a position in Precigen in Q3 2013 and has held it in 51 quarters since.
  • Morgan Stanley's Precigen position peaked at $101M in Q1 2016.
  • 205 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.